Vybion Overview

  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

Vybion General Information

Description

Operator of a patented drug discovery platform intended to offer proteins for diagnostics and therapeutic drugs. The company's platform develops a therapy for Huntington's disease by providing a small antibody fragment that is effective in both cell-based system and animal models, enabling healthcare professionals to deliver treatment for their patients and assist them in recovery.

Contact Information

Website
Formerly Known As
Viral Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 33 Thornwood Drive
  • Suite 104
  • Ithaca, NY 14850
  • United States
+1 (607) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vybion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC Completed Generating Revenue
4. Grant 01-Nov-2010 00000 Completed Generating Revenue
3. Grant 03-Dec-2009 00000 Completed Generating Revenue
2. Grant 01-Jan-2009 $127K Completed Generating Revenue
1. Debt - General 30-Sep-2005 Completed Generating Revenue
To view Vybion’s complete valuation and funding history, request access »

Vybion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a patented drug discovery platform intended to offer proteins for diagnostics and therapeutic drugs. The com
Biotechnology
Ithaca, NY
00000 00000

00000 00

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000000
Pittsburgh, PA
0 As of 0000
00.000
0000000000 0 00.000

000000 0

giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
0000000000000
Seattle, WA
00 As of 0000
00.00
0000000000 0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vybion Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sharp Edge Labs Venture Capital-Backed Pittsburgh, PA 0 00.000 0000000000 0 00.000
000000 00000000000 Venture Capital-Backed Seattle, WA 00 00.00 0000000000 0 00.00
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
000000000 Angel-Backed Albuquerque, NM 0 00000 000000000. 0 00000
0000000 Corporation Austin, TX 0000 000.00 00000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Vybion Executive Team (3)

Name Title Board Seat Contact Info
Rick Hendrick Chief Financial Officer
George Schneider Board Member, Treasurer & Secretary
Lee Henderson Ph.D Founder, Chief Executive Officer, President & Chairman of Board
To view Vybion’s complete executive team members history, request access »

Vybion Board Members (4)

Name Representing Role Since
George Schneider Vybion Board Member, Treasurer & Secretary 000 0000
Kenneth Bartels Self Board Member 000 0000
Lee Henderson Ph.D Vybion Founder, Chief Executive Officer, President & Chairman of Board 000 0000
Nitin Parekh Ph.D Self Board Member & Advisor 000 0000
To view Vybion’s complete board members history, request access »

Vybion Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Qualifying Therapeutic Discovery Project Government 000 0000 000000 0
Cayuga Venture Fund Venture Capital Minority 000 0000 000000 0
To view Vybion’s complete investors history, request access »